tiotropium bromide
Tiotropium bromide (Spiriva) is an inhaled medicine that relaxes the muscles around the airways by blocking muscarinic receptors. It is used once daily as long-term maintenance treatment to open the airways and reduce flare-ups in people with chronic obstructive pulmonary disease.
This page is based on FDA prescribing information for tiotropium bromide inhalation powder, cross-checked with the National Cancer Institute drug dictionary; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
The airways are like tubes wrapped in thin muscle bands. In COPD, a nerve signal tells those muscles to tighten, narrowing the tubes. Tiotropium sits on the muscle's receiver and blocks that tightening signal, so the tubes stay open and breathing is easier.
In simple terms
Tiotropium is an inhaled medicine that blocks muscarinic receptors, mainly the M3 type, on the smooth muscles surrounding the airways. Normally, a chemical called acetylcholine binds to these receptors and causes the muscles to contract, narrowing the airways. Tiotropium prevents this contraction, keeping the airways relaxed and open for at least 24 hours. It is used once daily as a maintenance treatment for chronic obstructive pulmonary disease and helps reduce flare-ups. It is not a rescue inhaler and should not be used for sudden breathing problems.
In depth
Tiotropium bromide is a quaternary ammonium derivative of atropine and a long-acting muscarinic receptor antagonist (LAMA). Upon inhalation, tiotropium binds with high affinity to muscarinic receptors M1 through M5, with particularly slow dissociation from the M3 receptor subtype located on airway smooth muscle. By blocking M3 receptor activation by acetylcholine, tiotropium inhibits parasympathetic bronchoconstriction and produces sustained bronchodilation lasting more than 24 hours. The functional antagonism at M3 receptors on airway smooth muscle reduces bronchomotor tone, improves lung function, and decreases dynamic hyperinflation in COPD. Tiotropium also reduces exacerbation frequency, likely through both bronchodilatory and anti-inflammatory effects on the airways. As a quaternary ammonium compound, tiotropium has limited systemic absorption and minimal central nervous system penetration when inhaled.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
The airways are like tubes wrapped in thin muscle bands.
- Tiotropium is an inhaled medicine that blocks muscarinic receptors, mainly the M3 type, on the smooth muscles surrounding the airways.
- Normally, a chemical called acetylcholine binds to these receptors and causes the muscles to contract, narrowing the airways.
- Tiotropium prevents this contraction, keeping the airways relaxed and open for at least 24 hours.
- It is not a rescue inhaler and should not be used for sudden breathing problems.
Target: Muscarinic M3 receptor
A G protein-coupled receptor on airway smooth muscle cells; when activated by acetylcholine it triggers bronchoconstriction. Tiotropium blocks this receptor to keep airways open.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- Long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
- Reduction of COPD exacerbations.
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: tiotropium bromide prescribing information
U.S. Food and Drug Administration
- National Cancer Institute: tiotropium bromide
National Cancer Institute
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.